UPDATE: Barclays Downgrades CytomX Therapeutics (CTMX) to Underweight
Tweet Send to a Friend
(Updated - May 28, 2021 6:03 AM EDT)
Barclays analyst Peter Lawson downgraded ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Peter Lawson downgraded ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
